Critical Congenital Heart Disease Newborn Screening Demonstration Program
Page 2

a) Enhancing and expanding the capacity of state and local public health agencies and hospitals in the process of providing screening, counseling, follow-up check-ups, performing necessary quality assurance, outcome analysis, as well as other public health surveillance functions.

b) Assisting in the process of providing health care professionals and newborn screening program personnel with ample education and knowledge on appropriate newborn screening practices, as well as on emerging technologies intended for critical congenital heart diseases.

c) Developing and administering educational programs that focus on critical congenital heart disease newborn screening, counseling, testing, follow-up, management, and treatment.

d) Establishing, sustaining, and operating a system that could coordinate and evaluate screening programs and follow-up check-ups with regards to critical congenital heart disease patients.

The Health Resources and Services Administration is willing to administer a total amount of $7,000,000 to be equally divided into seven different grant awardees.

The institutions and administrations who will be considered eligible to submit an application under this program are states or political subdivisions of a state, a consortium of two more states, a health facility, or any other entity that possess sufficient expertise in newborn screening.


Critical Congenital Heart Disease Newborn Screening Demonstration Program
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Physical and Engineering Sciences in Oncology
The National Science Foundation, in close cooperation the National Cancer Institute, has recently developed the Physical and Engineering Sciences in Oncology Program wherein they intend to obtain a more thorough understanding of cancer disorders with the application of physical and engineering sciences.

---

Mechanisms Mediating Osteoarthritis in Aging
The National Institutes of Health, in close cooperation with The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, has recently established a program called Mechanisms Mediating Osteoarthritis in Aging in an effort to improve and encourage the characterization of new and underutilized models in order to gain a deeper understanding of mechanisms that are involved in osteoarthritic progression.

---